NCT06975553
Extubation Safety Via Microstream EtCO₂ (IPI) Monitoring
StatusEnrolling by Invitation
PhaseNot applicable
SponsorChinese PLA General Hospital
Primary completion (estimated)
At risk: Primary completion moved 6 months later.
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 5 versions: 5 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Primary and study completion dates pushed to Dec 30, 2026
- Eligibility criteria expanded, about 12 words
- Publications: details revised at 3 of 3 entries
Notable Trial status: Not Yet Recruiting to Enrolling by Invitationv4 Show 4 more changesShow less
- Eligibility criteria expanded, about 56 words
- Study sites: 0 to 1
- Start date changed from estimate of Jul 25, 2025 to Jun 30, 2025
- Publications: details revised at 1 of 3 entries
- Notable Start date: Jun 25, 2025 to Jul 25, 2025v3
- Minor Start date: May 30, 2025 to Jun 25, 2025v2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Incidence of hypoxemia
Timeframe: immediately after extubation, 5 minutes after extubation, 10 minutes after extubation
Duration of hypoxemia
Timeframe: From extubation to discharge from the PACU.
Secondary (2)
Incidence of subclinical hypoxemia
Duration of subclinical hypoxemia
Arms and interventions
Group CNo intervention
Group C:the conventional extubation group
Group TExperimental
Group T:extubation group with IPI monitoring
Devices: endotracheal intubation-type end-tidal carbon dioxide sampling tube
Sites
1 site in 1 country
- Medtronic 20pBeijing, Beijing Municipality, China